₹261.15
₹-3.20 (-1.21%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹916 Cr
P/E
21.31
ROE
51.51%
ROCE
27.98%
About Wanbury Ltd
Wanbury is engaged in the business of pharmaceutical and related activities, including research.
Founded
1988
CEO
K Chandran
Employees
1,382
HQ
Navi Mumbai, India
About Wanbury Ltd
Wanbury is engaged in the business of pharmaceutical and related activities, including research.
Founded:1988
CEO:K Chandran
Employees:1,382
HQ:Navi Mumbai, India
Finished Products
1Sales
₹1,666.19Cr2Other Operating Revenue
₹3.26Cr3Export Incentive
₹2.65Cr4Exchange Difference
₹2.65Cr5Sale of Scrap
₹2.15CrRaw Materials
1Cost of Materials Consumed
₹826.40Cr2Purchase
₹32.38Cr3Purchases of Stock in Trade
₹15.98CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹359
52W Low
₹162
Volume80.35K
Avg VolumeN/A
Beta1.16
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
21.31x
Valuation
P/B Ratio
11.82x
Valuation
EPS
₹12.29
Valuation
Dividend Yield
0.00%
Valuation
ROE
51.51%
Profitability
ROCE
27.98%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
30.3%
International
69.7%
Outside India69.7%
India30.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
2.98x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
6.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.